105 related articles for article (PubMed ID: 8240736)
21. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
[TBL] [Abstract][Full Text] [Related]
22. Prospects for the treatment of B cell tumors using idiotypic vaccination.
George AJ; Stevenson FK
Int Rev Immunol; 1989; 4(4):271-310. PubMed ID: 2519930
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
Santos-Argumedo L; Gordon J; Heath AW; Howard M
Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
[TBL] [Abstract][Full Text] [Related]
24. In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder.
Palmieri C; Falcone C; Iaccino E; Tuccillo FM; Gaspari M; Trimboli F; De Laurentiis A; Luberto L; Pontoriero M; Pisano A; Vecchio E; Fierro O; Panico MR; Larobina M; Gargiulo S; Costa N; Dal Piaz F; Schiavone M; Arra C; Giudice A; Palma G; Barbieri A; Quinto I; Scala G
Blood; 2010 Jul; 116(2):226-38. PubMed ID: 20363775
[TBL] [Abstract][Full Text] [Related]
25. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
Weiner GJ; Hillstrom JR
J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
[TBL] [Abstract][Full Text] [Related]
26. [The experimental study on idiotypic DNA vaccine against human B-cell lymphoma to induce antitumor immune response].
Zhong KL; Zhang WJ; Yuan Y; Wu Y; Zhang MW; Mao N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):609-15. PubMed ID: 14706145
[TBL] [Abstract][Full Text] [Related]
27. Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state.
Farrar JD; Katz KH; Windsor J; Thrush G; Scheuermann RH; Uhr JW; Street NE
J Immunol; 1999 Mar; 162(5):2842-9. PubMed ID: 10072532
[TBL] [Abstract][Full Text] [Related]
28. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
[TBL] [Abstract][Full Text] [Related]
29. Mathematical models of cancer dormancy.
Page K; Uhr JW
Leuk Lymphoma; 2005 Mar; 46(3):313-27. PubMed ID: 15621821
[TBL] [Abstract][Full Text] [Related]
30. Cancer dormancy: role of cyclin-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgM.
Marches R; Scheuermann RH; Uhr JW
Cancer Res; 1998 Feb; 58(4):691-7. PubMed ID: 9485022
[TBL] [Abstract][Full Text] [Related]
31. Treatment of mice bearing BCL1 lymphoma with bispecific antibodies.
Brissinck J; Demanet C; Moser M; Leo O; Thielemans K
J Immunol; 1991 Dec; 147(11):4019-26. PubMed ID: 1940384
[TBL] [Abstract][Full Text] [Related]
32. Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma.
Barrios Y; Cabrera R; Yáñez R; Briz M; Plaza A; Forés R; Fernández MN; Díaz-Espada F
Haematologica; 2002 Apr; 87(4):400-7. PubMed ID: 11940484
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the idiotypic network in tumor immunity.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
[TBL] [Abstract][Full Text] [Related]
34. Vaccine therapy for B-cell lymphomas: next-generation strategies.
Neelapu SS; Kwak LW
Hematology Am Soc Hematol Educ Program; 2007; ():243-9. PubMed ID: 18024636
[TBL] [Abstract][Full Text] [Related]
35. Anti-idiotype MoAb effective in B-cell non-Hodgkin's lymphoma.
Oncology (Williston Park); 1994 Jun; 8(6):50, 79. PubMed ID: 8074982
[No Abstract] [Full Text] [Related]
36. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.
Kwak LW; Campbell MJ; Czerwinski DK; Hart S; Miller RA; Levy R
N Engl J Med; 1992 Oct; 327(17):1209-15. PubMed ID: 1406793
[TBL] [Abstract][Full Text] [Related]
37. Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells.
Marches R; Racila E; Tucker TF; Picker L; Mongini P; Hsueh R; Vitetta ES; Scheuermann RH; Uhr JW
Ther Immunol; 1995 Jun; 2(3):125-36. PubMed ID: 8885131
[TBL] [Abstract][Full Text] [Related]
38. Gangliosides, Ab1 and Ab2 antibodies III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent manner.
López-Requena A; Bestagno M; Mateo de Acosta C; Cesco-Gaspere M; Vázquez AM; Pérez R; Burrone OR
Mol Immunol; 2007 Apr; 44(11):2915-22. PubMed ID: 17316805
[TBL] [Abstract][Full Text] [Related]
39. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
[TBL] [Abstract][Full Text] [Related]
40. High idiotypic connectivity of the VH7183-encoded antibodies directed to a murine embryonic carbohydrate antigen, Lewis Y, as ascertained by syngenic anti-idiotype monoclonal antibodies.
Hirashima K; Zenita K; Takada A; Kitahara A; Ishihara G; Harada R; Ohmori K; Hirohashi S; Kyoizumi S; Akiyama M
J Immunol; 1990 Jul; 145(1):224-32. PubMed ID: 1972718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
